Skip to main content
SpringerLink
Log in
Book cover

In-vitro- und in-vivo-Untersuchungen zur selektiven Immunadsorptionsbehandlung neurologischer Erkrankungen pp 81–91Cite as

Literatur

  • Chapter

Part of the book series: Schriftenreihe Neurologie ((NEUROSER,volume 33))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aarli JA, Behan WMH, Behan PO (eds) (1987) Clinical neuroimmunology. Blackwell, Oxford

    Google Scholar 

  • Abel JJ, Rowntree LG, Turner BB (1914) Plasma removal with return of corpuscles. J Pharm Exp Ther 5: 625–641

    CAS  Google Scholar 

  • Adler H (1937) Thymus und Myasthenie. Arch Klin Chir 189: 529–532

    Google Scholar 

  • Agishi T (1983) Technical aspects of double filtration plasmapheresis. Plasma Ther Transfus Technol 4: 397–404

    CAS  Google Scholar 

  • Agishi T, Kaneko I, Hasuo Y et al. (1980) Double filtration plasmapheresis. Trans Am Soc Artif Intern Org 26: 406–411

    CAS  Google Scholar 

  • Akizawa T, Koshikawa S (1987) Activated complement and leukotrien profiles during membrane plasmapheresis: indices of blood membrane interaction. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis, Vol VI. IS AO Press, Cleveland, pp 44–50

    Google Scholar 

  • Aufeuvre JP, Morin F, Cohen-Solal M, Lefloch A, Baudelot J (1980)Hazards of plasma exchange. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, S 149–157

    Google Scholar 

  • Austin JH (1965) Recurrent polyneuropathies and their cortico-steroid treatment. Brain 81: 157–192

    Article  Google Scholar 

  • Barandun S, Morell A (1981) Adverse reactions to immunoglobulin preparations. In: Nydegger UE (ed) Immunohemotherapy. A guide to immunoglobulin prophylaxis and therapy. Academic Press, London, p 223

    Google Scholar 

  • Behan PO, Behan WMH (1987) Plasma exchange in neurological diseases. Brit Med J 295: 283–284

    Article  CAS  Google Scholar 

  • Behm E, Falkenhagen D, Zinner G, Courtney JM, Klinkmann H (1987) Interactions of IM-P and IM-T adsorbents with complement components. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis, Vol VI. IS AO Press, Cleveland, pp 493–498

    Google Scholar 

  • Benedik M, Drinovec J, Varl J, Ponikvar R, Koselj M (1988) The influence of chronic plasma exchange on serum aluminium levels in a patient with normal renal function. In: Rock G (ed) Apheresis. Alan R. Liss, New York

    Google Scholar 

  • Berger GMB, Miller JL, Bonnici F, HA Joffe, DW Dubovsky (1978) Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia.Am J Med 65: 243–251

    CAS  Google Scholar 

  • Berning T, Krummenerl T, Glaser J, Paulus H, van Husen N (1988) Immunadsorption - eine neue Therapie der Myasthenia gravis. Med Klin 83: 125–128

    CAS  Google Scholar 

  • Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia gravis: Long term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33: 1316–1321

    Google Scholar 

  • Besinger UA, Fateh-Moghadam A, Knorr-Held S, Wick M, Kissel H, Albiez M (1987) Immunomodulation in myasthenia gravis by high-dose intravenous 7-S immunoglobulins. Ann NY Acad Sei 505: 828–831

    Article  Google Scholar 

  • Biggs R (ed) (1976)Human Blood Coagulation, Hemostasis and Thrombosis. Blackwell, Oxford

    Google Scholar 

  • Blalock A (1944) Thymectomy in the treatment of myasthenia gravis. J Thorac Surg 13: 316–339

    Google Scholar 

  • Borberg H (1981) Problems of plasma exchange therapy. In: Gurland HJ, Heinze V, Lee HA (eds) Therapeutic plasma exchange. Springer, Berlin Heidelberg New York, S 191–201

    Chapter  Google Scholar 

  • Borberg H, Stoffel W, Oette K (1983) The development of specific plasma immunoabsorption.Plasma Ther Transfus Technol 4: 459–466

    Google Scholar 

  • Burgstaler E, Pineda AA (1981) Immunoabsorption in an extracorporeal plasma perfusion system: in vitro studies.Artif Organs 5: 259

    CAS  Google Scholar 

  • Behan PO, Behan WMH (1987) Plasma exchange in neurological diseases. Brit Med J 295: 283–284

    Article  CAS  Google Scholar 

  • Bystryn JC, Graf MW, Uhr JW (1970) Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 132: 1279–1287

    Google Scholar 

  • Castino F, Scheucher K, Malchesky PS, Koshino I, Nose Y (1976) Microemboli-free blood detoxification utilizing plasma filtration. Trans Am Soc Artif Intern Organs 22: 637–645

    PubMed  CAS  Google Scholar 

  • Charlton B, Schindhelm K, Smeby LC, Farrell PC (1985) Analysis of immunoglobulin G kinetics in the non-steady state J Lab Clin Med 105: 312–320

    CAS  Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Co Tui, Bartter FC, Wright AM, Holt RB (1944) Red cell reinfusion and the frequency of plasma donations. JAMA 124: 331–336

    Google Scholar 

  • Consensus Development Conference, National Institutes of Health. (1986) The utility of therapeutic plasmapheresis for neurological disorders. JAMA 256: 1333–1337

    Article  Google Scholar 

  • Cook SK, Dowling PC, Murray MR, Whitaker JN (1971) Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 24: 136–144

    PubMed  CAS  Google Scholar 

  • Craddock PR, Hammerschmidt DE, White JG, Dalmasso AP, Jacob HS (1977) Complement (C5a)-induced granulocyte aggregation in vitro: A possible mechanism of complement-mediated leukostasis and leukopenia. J Clin Invest 60: 260–264

    Google Scholar 

  • Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD (1965) Blood volume measurement: A critical study.Adv Surg 1: 69–109

    CAS  Google Scholar 

  • Dalakas MC, Engel WK (1981) Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment.Ann Neurol (Suppl) 9: 134–145

    Google Scholar 

  • Dau PC (1980) Plasmapheresis therapy in myasthenia gravis.Muscle Nerve 3: 468–482

    Article  CAS  Google Scholar 

  • Dau PC (1984) Plasmapheresis: Therapeutic or experimental procedure? Arch Neurol 41: 647–653

    PubMed  CAS  Google Scholar 

  • Delwaide PJ, Salmon J, von Cauwenberger H (1967) Premiers essais de traitement de la myasthenie par azathioprine. Acta Neurol Belg 67: 701–712

    CAS  Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV (1975) Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50: 621–637

    PubMed  CAS  Google Scholar 

  • Dyck PJ, Lais AC, Hansen SM, Sparks MF, Low PA, Parathasarathy S, Baumann WJ (1982) Technique assessment of demyelination from endoneurial injection. Exp Neurol 77: 359–377

    Article  PubMed  CAS  Google Scholar 

  • Dyck PJ, O’Brien PC, Oviatt KF et al. (1982) Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 11: 136–141

    Article  PubMed  CAS  Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Dyck PJ, Daube J, O’Brien P, Pineda A, Low PA, Windebank AJ, Swanson C (1986) Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 314: 461–465

    Article  PubMed  CAS  Google Scholar 

  • Edelman GM, Marchalonis JJ (1967) Preparation of antigens and antibodies. In: Williams CA, Chase MW (eds) Methods in Immunology and Immunochemistry, Vol I.Academic Press, New York

    Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Engel AG, Sahashi K, Lambert EH, Howard FM (1979) The ultrastructural localization of the acetylcholine receptor, immunoglobulin G and the third and ninth complement component at the motor end-plate and their implications for the pathogenesis of myasthenia gravis. In: Aguayo AJ, Karpati G (eds) Current topics in nerve and muscle research. Excerpta Medica, Amsterdam, pp 111–122

    Google Scholar 

  • Euler HH, Krey U, Schroeder O, Lofiler H (1985) Membrane plasmapheresis technique in rats. Confirmation of antibody rebound. J Immunol Methods 84: 313–319

    Google Scholar 

  • Euler HH, Schroeder JO, Löffler H (1987) The antibody rebound phenomenon as a rationale for synchronizing plasmapheresis with pulse cytotoxic drugs. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis, Vol VI. IS AO Press, Cleveland, pp 200–207

    Google Scholar 

  • Fabre M, Andreu G, Mannoni P (1980) Some biological modifications and clinical hazards observed during plasma exchanges. In: Sieberth HG (ed) Plasma Exchange. Schattauer, Stuttgart, pp 143–148

    Google Scholar 

  • Forsgren A, Sjöquist J (1966) Protein A from Staphylococcus aureus. I. Pseudo-immune reaction with human gammaglobulin. J Immunol 97: 822–827

    Google Scholar 

  • Frank MM, Hamburger MI, Lawley TJ, Kimberley RP, Plötz PH (1979) Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518–523

    Article  PubMed  CAS  Google Scholar 

  • French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome (1987) Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. Ann Neurol 22: 753–761

    Article  Google Scholar 

  • Ghebrehiwet B, Müller-Eberhard HJ (1979) C3e: an acidic fragment of human C3 with leukocytosis-inducing activity. J Immunol 123: 616–621

    PubMed  CAS  Google Scholar 

  • Gibbels E, Toyka KV, Borberg H, Haupt WF, Hann P (1986) Plasmaaustauschbehandlung bei chronischen Polyneuritiden vom Typ Guillain-Barre. Nervenarzt 57: 129–139

    PubMed  CAS  Google Scholar 

  • Goudswaard J, Virella G, Noordzij A, Pol J (1977) Isolation of equine IgG ( T) by hydrophobic interaction chromatography. Immunochemistry 14: 717–719

    Google Scholar 

  • Graw RG, Herzig GP, Eisel RS, Perry S (1971) Leucocyte and platelet collection from normal donors with the continuous flow blood cell separator. Transfusion 11: 94–101

    Article  PubMed  Google Scholar 

  • Grob D (ed) (1981) Myasthenia gravis: Pathophysiology and management. Ann NY Acad Sei 377

    Google Scholar 

  • Gross MLP, Thomas PK (1981) The treatment of chronic relapsing and chronic progressive idiopathic inflammatory polyneuropathy by plasma exchange. J Neurol Sei 52: 69–78

    Article  CAS  Google Scholar 

  • Grossman L (1985) Are sham procedures needed in clinical trials of plasmapheresis? Plasma Ther Transfus Technol 6: 780–786

    Google Scholar 

  • Güsken G, Kotitschke R, Gaczkowski A, Kadar J, Borberg H (1987) Serum preserve as a replacement fluid for plasma exchange therapy. Plasma Ther Transfus Technol 8: 333–341

    Article  Google Scholar 

  • Guillain-Barré Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome Neurology 35: 1096–1104

    Google Scholar 

  • Handley SL (1981) Therapeutic apheresis: industry research report. Unterberg & Towbin, New York

    Google Scholar 

  • Härtung H-P, Hadding U. (1983) Synthesis of complement by macrophages and modulation of their functions through complement activation. Springer Semin Immunopathol 6: 283–326

    Article  PubMed  Google Scholar 

  • Härtung H-P, Schwenke C, Bitter-Suermann D, Toyka KV (1987) Guillain-Barré syndrome: Activated complement components C3a and C5a in CSF. Neurology 37: 1006–1009

    PubMed  Google Scholar 

  • Härtung H-P, Heininger K, Schäfer B, Fierz W, Toyka KV (1988) Immune mechanisms in inflammatory polyneuropathy. Ann NY Acad Sei 540: 122–161

    Article  Google Scholar 

  • Heininger K, Liebert UG, Toyka KV et al. (1984) Chronic inflammatory polyneuropathy: Reduction of nerve conduction velocities in monkeys by systemic passive transfer of immunoglobulins. J Neurol Sei 66: 1–14

    Google Scholar 

  • Heininger K, Hendricks M, Toyka KV (1985) Myasthenia gravis: A new semiselective procedure to remove acetyl-choline receptor autoantibodies from plasma. Plasma Ther Transfus Technol 6: 771–775

    Google Scholar 

  • Heininger K (1986) Stellenwert der Bestimmung der Acetylcholin-Rezeptorantikörper in der Diagnostik und Verlaufsbeurteilung der Myasthenia gravis. Dissertation, München

    Google Scholar 

  • Heininger K, Toyka KV, Gaczkowski A, Härtung H-P, Borberg H, Grabensee B (1986) Selective removal of pathogenic factors in neurologic diseases. Plasma Ther Transfus Technol 7: 351–357

    CAS  Google Scholar 

  • Heininger K, Härtung H-P, Toyka KV, Gaczkowski A, Borberg H (1987) Therapeutic plasma exchange in myasthenia gravis: Semiselective adsorption of anti-AChR autoantibodies with tryptophane-linked polyvinylalcohol gels. Ann NY Acad Sei 505: 898–900

    Google Scholar 

  • Heininger K, Toyka KV, Borberg H (1987) Selective removal of antibodies: Theoretical and practical aspects. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic Plasmapheresis, Vol VI. ISAO Press, Cleveland, pp 136–142

    Google Scholar 

  • Heininger K, Toyka KV (1988) Current status of plasma exchange in neurology. Plasma Ther Transfus Technol 9: 69–72

    Article  Google Scholar 

  • Heininger K, Toyka KV, Gibbels E, Besinger UA, Borberg H, Härtung H-P, Grabensee B (1990) Role of therapeutic plasmapheresis in chronic inflammatory demyelinating polyneuropathy. Prog Clin Biol Res 337: 275–281

    PubMed  CAS  Google Scholar 

  • Hellstrom KE, Hellstrom I (1981) Does perfusion with treated plasma cure cancer? N Engl J Med 305: 1215–1216

    Article  PubMed  CAS  Google Scholar 

  • Hugli TE, Chenoweth DE (1980) Biologically active peptides of complement: techniques and significance of C3a and C5a measurement. In: Nakamura RM (ed) Future Perspectives in Clinical Laboratory Immunoassays. Alan R. Liss, New York

    Google Scholar 

  • Iizuka I, Yamazaki Z, Kanai F (1984) A study of direct hemoperfusion using a new immunocomplex adsorbent IMP. In: Oda T (ed), Therapeutic Plasmapheresis, Vol III. Schattauer, Stuttgart, pp 277–282

    Google Scholar 

  • Ilyas AA, Willison HJ, Quarles RH et al. (1988) Serum antibodies to gangliosides in Guillain-Barrd syndrome. Ann Neurol 23: 440–447

    Article  PubMed  CAS  Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Kanazawa H, Nagasato K, Shirabe M, Kihara M, Shibuya N (1985) Changes of lymphocyte subsets during plasmapheresis. In: Oda T (ed) Therapeutic Plasmapheresis, Vol IV. Schattauer, Stuttgart, pp 561–565

    Google Scholar 

  • Khatri, BO, McQuillen MP, Harrington GJ, Sachmoll D, Hoffmann RG (1985) Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 35: 312–319

    PubMed  CAS  Google Scholar 

  • Klein J (1982) Immunology. The science of self-nonself discrimination. Wiley, New York

    Google Scholar 

  • Koski CL, Humphry R, Shin ML (1985) Anti-peripheral myelin antibody in patients with demyelinating polyneuropathy: Quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc Natl Acad Sci USA 82: 905–909

    Article  PubMed  CAS  Google Scholar 

  • Koski CL, Chou D, Jungalwala FB (1987) Myelin lipids bound by serum antibodies to peripheral myelin (a-PNM Ab) in patients with Guillain-Barre syndrome. Neurology 37: 253 (abstract)

    Google Scholar 

  • Kronvall G, Williams RC (1969) Differences in anti-protein A activity among IgG subgroups. J Immunol 103: 828–833

    PubMed  CAS  Google Scholar 

  • Leibowitz S, Hughes RAC (1983) Immunology of the nervous system. Arnold, London

    Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Limburg PC, The H, Hummel-Tappel E, Oosterhuis HJGH (1983) Anti acetylcholine receptor antibodies in myasthenia gravis. I. Their relation to the clinical state and the effect of therapy. J Neurol Sci 58: 357–370

    Google Scholar 

  • Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD (1976) Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054–1059

    PubMed  CAS  Google Scholar 

  • Lindstrom JM, Campbell M, Nave B (1978) Specificities of antibodies to acetylcholine receptors-Muscle Nerve 1: 140–145

    CAS  Google Scholar 

  • Lisak RP (1984) Plasma exchange in neurologic diseases. Arch Neurol 41: 654–657

    PubMed  CAS  Google Scholar 

  • Lisak RP, Abramsky O, Schotland DL (1979) Plasmapheresis in the treatment of myasthenia gravis: Preliminary study in 21 patients. In: Daun PC (ed) Plasmapheresis and the immunobiolog of myasthenia gravis. Houghton Mifflin, Boston, pp 209–215

    Google Scholar 

  • Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300: 524

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folinphenol reagent. J Biol Chem 193: 265–275

    PubMed  CAS  Google Scholar 

  • Malchesky PS, Asanuma Y, Zawicki I et al. (1980) On-line separation of macromolecules by membrane filtration with eryogelation. Artif Organs 4: 205–206

    Article  PubMed  CAS  Google Scholar 

  • Mandy WJ, Nisonoff A (1963) Effect of reduction of several disulfide bonds on the properties and recombination of univalent fragments of rabbit antibody. J Biol Chem 238: 206–213

    Google Scholar 

  • McCombe PA, Pollard JD, McLeod JG (1987) Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 110: 1617–1630

    Article  PubMed  Google Scholar 

  • McCune MA, Winkelmann RK, Osmundson PJ, Pineda AA (1983) Plasma exchange: a controlled study of the effect in patients with Raynaud’s phenomenon and scleroderma. J Clin Apheresis 1: 206–214

    Article  PubMed  CAS  Google Scholar 

  • Mertens HG, Balzereit F, Leipert H (1969) The treatment of myasthenia gravis with immunosuppressive agents.Eur Neurol 2: 321–329

    CAS  Google Scholar 

  • Messerschmidt GL, Henry DH, Snyder HW jr et al. (1988) Protein A immunoadsorption in the treatment of malignant disease. J Clin Oncol 6: 201–212

    Google Scholar 

  • Meyer B-U, Benecke R, Göhmann M, Zipper S, Conrad B (1987) Möglichkeiten und Grenzen der Bestimmung zentraler motorischer Leitungszeiten beim Menschen. Z EEG EMG 18: 165–172

    CAS  Google Scholar 

  • Mittag T, Kornfeld P, Tormay A, Woo C (1976) Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med 294: 691–694

    Article  PubMed  CAS  Google Scholar 

  • Murabayashi S, Omokawa S, Takaoka T, Malchesky PS, Nose Y (1987) Biocompatibility in membrane plasmapheresis: the necessity of global understanding. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis, Vol VI. IS AO Press, Cleveland, pp 27–43

    Google Scholar 

  • Newsom-Davis J (1979) Plasma exchange in myasthenia gravis. Plasma Ther 1: 17–31

    Google Scholar 

  • Nikolay J, Braun J, Druschky KF, Greiling HW, Gessler U (1987) Klinische Erfahrung mit der Immunadsorption bei Myasthenia gravis und Polyradikuloneuritis. Nieren Hochdruckkrankh 11: 455–460

    Google Scholar 

  • Nisonoff A, Wissler FC, Lipman LN, Woernley DL (1960) Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys 89: 230–244

    Article  PubMed  CAS  Google Scholar 

  • Oh SJ (1978) Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch Neurol 35: 509–516

    PubMed  CAS  Google Scholar 

  • Oosterhuis HJGH (1984) Myasthenia gravis. Churchill Livingstone, Edinburgh

    Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Patrick J, Lindstrom J (1973) Autoimmune response to acetylcholine receptor. Science 180: 871–872

    Article  PubMed  CAS  Google Scholar 

  • Patten E (1986) Therapeutic plasmapheresis and plasma exchange CRC Crit Rev Clin Lab Sei 23: 147–175

    Article  CAS  Google Scholar 

  • Peterson EA (1970) Cellulosic ion exchangers. In: Work TS, Work E (eds) Laboratory techniques in biochemistry and molecular biology, Vol 2, Part II. North Holland, Amsterdam

    Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Pineda AA (1985) Apheresis controlled trials: the need for sham procedures-Plasma Ther Transfus Technol 6: 777–780

    Google Scholar 

  • Pollard JD, McLeod JG, Gatenby P, Kronenberg H (1983) Prediction of response to plasma exchange in chronic relapsing polyneuropathy. J Neurol Sei 58: 269–287

    Article  CAS  Google Scholar 

  • Pollard JD (1987) A critical review of therapies in acute and chronic inflammatory emyelinating polyneuropathies-Muscle Nerve 10: 214–221

    CAS  Google Scholar 

  • Prineas JW, McLeod JG (1976) Chronic relapsing polyneuritis. J Neurol Sei 27: 427–458

    Article  CAS  Google Scholar 

  • Rao VS, Grodzicki RL, Mitchell MS (1979) Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes. Cancer Res 39: 174–182

    PubMed  CAS  Google Scholar 

  • Ratnam M, Le Nguyen D, Rivier J, Sargent P, Lindstrom J (1986) Transmembrane topography of the nicotinic acetylcholine receptor: immunochemical tests contradict theoretical predictions based on hydrophobicity profiles. Biochemistry 25: 2633–2643

    Article  PubMed  CAS  Google Scholar 

  • Reis G von, Liljestrand A, Matell G (1966) Treatment of severe myasthenia gravis with large doses of ACTH. Ann NY Acad Sei 135: 409–416

    Article  Google Scholar 

  • Rifle G, Tanter Y, Mousson C, Cabanne JF, Chalopin JM (1986) Hazards of plasma exchange: experience of a single center. First International Congress World Apheresis Association. Abstracts, p 50

    Google Scholar 

  • Roberts WH, Domen RE, Wanger GP, Kennedy MS (1983) Acute copper deficiency in patients undergoing plasma exchange. In: Nose Y, Malchesky PS, Smith JW, Krakauer RS (eds) Plasmapheresis. Raven Press, New York, pp 395–398

    Google Scholar 

  • Rodnitzky RL, Goeken JA (1982) Complications of plasma exchange in neurological patients. Arch Neurol 39: 350–354

    PubMed  CAS  Google Scholar 

  • Rosengren J, Pahlman S, Glad M (1975) Hydrophobic Interaction Chromatography on non-charged Sepharose derivatives. Biochim Biophys Acta 412: 51–61

    PubMed  CAS  Google Scholar 

  • Roitt I, Brostoff J, Male D (1985) Immunology. Gower, London

    Google Scholar 

  • Saida T, Saida K, Silberberg DH, Brown MJ (1982) In vivo demyelinating activity of sera from patients with Guillain-Barre syndrome. Ann Neurol 11: 69–75

    Article  PubMed  CAS  Google Scholar 

  • Salinas, FA, Hanna MG jr (eds) Immune complexes and human cancer. In: Contemporary topics in immunobiology, Vol 15. Plenum Press, New York

    Google Scholar 

  • Samtleben W, Hillebrand G, Krumme D, Gurland HJ (1980) Membrane plasma separation: clinical experience with more than 120 plasma exchanges. In: Sieberth HG (ed) Plasma exchange. Schattauer, Stuttgart, pp 175–178

    Google Scholar 

  • Sanaka T, Kubo K, Suzuki T et al. (1983) Complications associated with plasma exchange. In: Oda T (ed) Therapeutic plasmapheresis, Vol II Schattauer, Stuttgart, pp 585–589

    Google Scholar 

  • Sanders ME, Koski CL, Robbins D (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barrd syndrome and multiple sclerosis. J Immunol 136: 4456–4459

    PubMed  CAS  Google Scholar 

  • Sato T, Nishimiya J, Arai K, Anno M, Yamawaki M, Kuroda T, Inagaki K (1984) Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunosorbent. In: Oda T (ed) Therapeutic Plasmapheresis, Vol III. Schattauer, Stuttgart, pp 565–568

    Google Scholar 

  • Scheidegger JJ (1955) Une micro-méthode de l’immuno-électrophorése. Int Arch Allergy 7: 103–110

    Article  PubMed  CAS  Google Scholar 

  • Schmidt RE, Deicher H (1983) Indikationen zur Anwendung intravenöser Immunglobuline. Dtsch Med Wochenschr 108: 227–231

    Article  PubMed  CAS  Google Scholar 

  • Schmitt E, Behm E, Buddenhagen F et al. (1988) Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis - First results of a double blind controlled trial. In: Rock G (ed) Apheresis. Alan R. Liss, New York

    Google Scholar 

  • Schröder JO, Euler HH (1988) Antibody rebound secondary to antibody depletion: experimental evidence and clinical consequences. In: Rock G (ed), Apheresis Alan R. Liss, New York, im Druck

    Google Scholar 

  • Schumacher CH, Roth P (1912) Thymektomie bei einem Fall von Morbus Basedowi mit Myasthenie. Mitteilung Grenzgeb Med Chir 25: 746–765

    Google Scholar 

  • Schwab PJ, Fahey JL (1960) Treatment of Waldenstrom’s macroglobulinemia by plasmapheresis. N Engl J Med 263: 574–579

    Article  PubMed  CAS  Google Scholar 

  • Seki K, Sato T, Komiya T, Ishigaki Y, Kagamihara Y, Tsuda H (1987) Immunodasorption of acetylcholine-receptor antibodies in myasthenia gravis. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic Plasmapheresis, Vol VI. ISAO Press, Cleveland, pp 367–370

    Google Scholar 

  • Sela M, Mozes E (1966) Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Biochemistry 55: 445–452

    CAS  Google Scholar 

  • Sela M, Mozes E, Shearer GM, Karniely Y (1970) Cellular aspects of the inverse relationship between the net charge of immunogens and of antibodies elicited. Proc Natl Acad Sei 67: 1288–1293

    Article  CAS  Google Scholar 

  • Shibuya N, Shirabe S, Nagasato K, Kanazawa H, Kihara M (1985) Immunoadsorbent plasma perfusion therapy in patients with neuro-immunological disorders. In: Oda T (ed) Therapeutic plasmapheresis, Vol IV. Schattauer, Stuttgart, pp 165–169

    Google Scholar 

  • Shibuya N, Nagasato K, Shibayama K, Kanazawa H (1987) Immunoadsorption therapy in neurologic diseases: Myasthenia gravis, multiple sclerosis, and Guillain-Barré syndrome. In: Oda T, Shiokawa Y, Inoue N (eds) Therapeutic plasmapheresis, Vol VI ISAO Press, Cleveland, pp 122–128

    Google Scholar 

  • Sieberth HJ, Glöckner WM, Kierdorf H (1980) Cascade filtration for separating plasma proteins of different molecular weights. Proc EDTA 17: 347–352

    CAS  Google Scholar 

  • Simpson JA (1960) Myasthenia gravis: a new hypothesis. Scott Med J 5: 419–436

    Google Scholar 

  • Skoog WA, Adams WS (1959) Plasmapheresis in a case of Waldenstrom’s macroglobulinaemia. Clin Res 7: 96–99

    Google Scholar 

  • Smolens J, Stokes J, Vogt AB (1957) Human plasmapheresis and its effect on autoantibodies. J Immunol 79: 434–439

    PubMed  CAS  Google Scholar 

  • Sprenger KBG, Kratz W, Huber K, Franz HE (1983) On the quantification of plasma exchange: biological and economical considerations. In: Klinkmann H, Ahrenholz P, Biester FD, JM Courtney, Falkenhagen D, Gaylor JD (eds) Proc. Intern. Symp. on Kinetic Modelling in Artificial Organs. ISAO Press, Rostock, pp 214–218

    Google Scholar 

  • Sprenger KBG, Rasche H, Franz HE (1984) Membrane plasma separation: Complications and monitoring. Artif Organs 8: 360–363

    Google Scholar 

  • Sprenger KBG (1985) Plasmapherese. Habilitationsschrift, Düsseldorf

    Google Scholar 

  • Sprenger KBG (1987) Plasmaaustauschtherapie. Antrittsvorlesung, Düsseldorf

    Google Scholar 

  • Sterz R, Hohlfeld R, Rajki K, Kaul M, Heininger K, Peper K, Toyka KV (1986) Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab’)2 hybrid molecules. Muscle Nerve 9: 306–312

    Article  PubMed  CAS  Google Scholar 

  • Steward MW, Steensgard J (1983) Antibody affinity: thermodynamic aspects and biological significance. CRC Press, Boca Raton

    Google Scholar 

  • Stockinger B, Lemmel E-M (1978) Fc receptor dependency of antibody mediated feedback regulation: on the mechanism of inhibition Cell. Immunol 40: 395–403

    CAS  Google Scholar 

  • Stöhr M, Bluthardt M (1984) Atlas der klinischen Elektromyographie und Neurographie.Kohlhammer, Stuttgart

    Google Scholar 

  • Chenoweth DE, Cheung AK (1983) Anaphylatoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24: 764 – 769

    Article  PubMed  CAS  Google Scholar 

  • Sturgill BC, Worzniak MJ (1970) Stimulation of proliferation of 19S antibody-forming cells in the spleens of immunized guinea-pigs after exchange transfusion. Nature 228: 1304–1305

    Article  PubMed  CAS  Google Scholar 

  • Sugiyama H, Benda P, Meunier J, Changeux JP (1973) Immunological characterisation of the cholinergic receptor protein from Electrophorus electricus. FEBS Lett 35: 124–128

    Article  PubMed  CAS  Google Scholar 

  • Sutton DMC, Cardella CJ, Uldall PR, Deveber GA (1981) Complications of intensive plasma exchange. Plasma Ther 2: 19–23

    Google Scholar 

  • Sutton DMC (1986) Complications of therapeutic plasma exchange ( TPE) - the Canadian experience. First International Congress World Apheresis Association (Abstracts) p 49

    Google Scholar 

  • Szpirt W, Somnier F, Gammeltoft S (1987) Removal of anti-acetylcholine receptor antibodies by immunoadsorption to protein A column. In: Bambauer R, Malchesky PS, Falkenhagen D (eds) Therapeutic Plasma Exchange and Selective Plasma Separation. Schattauer, Stuttgart, pp 385–391

    Google Scholar 

  • Terman DS, Durante D, Buffaloe G, Mcintosh R (1977) Attenuation of canine nephrotoxic glomerulonephritis with an extracorporeal immunoadsorbent. Scand J Immunol 6: 195–202

    Article  PubMed  CAS  Google Scholar 

  • Terman DS (1983) Immunoadsorbents in autoimmune and neoplastic diseases. Plasma Ther Transfus Technol 4: 415–433

    Google Scholar 

  • Thomas PK, Lascelles RG, Hallpike JF, Hewer RL (1969) Recurrent and chronic relapsing Guillain-Barre polyneuritis. Brain 92: 589–606

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV, Drachman DB, Pestronk A, Kao I (1975) Myasthenia gravis: Passive transfer from man to mouse. Science 190: 397–399

    Google Scholar 

  • Toyka KV, Becker T, Fateh-Moghadam A et al. (1979) Die Bedeutung der Bestimmung von Antikörpern gegen Acetylcholinrezeptoren in der Diagnostik der Myasthenia gravis. Klin Wochenschr 57: 937–942

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV, Löwenadler B, Heininger K, Besinger UA, Birnberger KL, Fateh-Moghadam A, Heilbronn E (1980) Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG. J Neurol Neurosurg Psychiatry 43: 836–840

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV, Besinger UA, Heininger K et al. (1981) Myasthenia gravis: The pathogenic role of antibodies to acetyl-choline recptor and the effect of antibody depletion. In: Borberg H, Reuther P (eds) Plasma exchange therapy. Thieme, Stuttgart, pp 172–179

    Google Scholar 

  • Toyka KV, Augspach R, Wiethölter H et al. (1982) Plasma exchange in chronic inflammatory polyneuropathy: evidence suggestive of a pathogenic humoral factor. Muscle Nerve 5: 479–484

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV (1984) Neurologische Indikation zur Plasmapherese. Aktuel Neurol 11: 114–117

    Article  Google Scholar 

  • Toyka KV, Heininger K (1986) Acetylcholin-Rezeptor-Antikörper in der Diagnostik der Myasthenia gravis. Dtsch med Wochenschr 111: 1435–1439

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV, Heininger K (1987) Humoral factors in peripheral nerve disease. Muscle Nerve 10: 222–232

    Article  PubMed  CAS  Google Scholar 

  • Toyka KV (1987) Klinische Neuroimmunologie. VCH Verlagsgesellschaft, Weinheim

    Google Scholar 

  • Tullis JL, Trich RJ, Bavdanza P (1971) Plateletpheresis in a disposable system. Transfusion 11: 368–377

    Article  PubMed  CAS  Google Scholar 

  • Tsuruta Y, Maeda K, Shinzato T et al. (1983) Clinical application of improved 1–02 immunosorbent column. In: Nos6 Y, Malchesky PS, Smith JW (eds), Plasmapheresis ISAO Press, Cleveland, pp 149–154

    Google Scholar 

  • Tyka WM (1984) Möglichkeiten und Grenzen der Membranplasmaseparation. Dissertation, Dusseldorf Tzartos S, Seybold M, Lindstrom J (1982) Specificity of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sei USA 79: 188–192

    Google Scholar 

  • Tzartos S, Langeberg L, Hochschwender S, Lindstrom J (1983) Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett 158: 116–118

    Article  PubMed  CAS  Google Scholar 

  • Underdo wn BJ, Good friend L (1970) Correlation of charge properties of human reaginic antibodies with charge of the corresponding allergens. J Immunol 104: 530–533

    PubMed  CAS  Google Scholar 

  • Vermeulen M, van der Meche FGA, Speelman JD, Weber A, Busch HFM (1985) Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy. J Neurol Sei 70: 317–326

    Article  CAS  Google Scholar 

  • Viets HR, Schwab RS (1960) Thymectomy for Myasthenia Gravis. Thomas, Springfield, 111.

    Google Scholar 

  • Vincent A (1980) Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev 60: 756–824

    PubMed  CAS  Google Scholar 

  • Yamazaki Z, Fujimoto Y, Sanjo K et al. (1978) New artificial liver support system (plasma perfusion detoxification) for hepatic coma. Artif Organs 2 (S): 273–276

    Article  Google Scholar 

  • Yamazaki Z, Fujimori Y, Takahama T et al. (1982) Efficiency and biocompatibility of a new immunosorbent. Trans Am Soc Artif Intern Organs 28: 318–323

    PubMed  CAS  Google Scholar 

  • Yamazaki Z, Fujimori Y, Iizoka I et al. Immunoadsorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus In: Atsumi K, Maekawa M, Ota K (eds) Progress in artificial organs. ISAO Press, Cleveland, pp 708–712 (1983)

    Google Scholar 

  • Yang B-H, Sundaram PV, Maelicke A (1981) Affinity chromatography and immunosorption with acetylcholine receptor attached to nylon tubes. Biochem J 199: 317–322

    PubMed  CAS  Google Scholar 

  • Waldmann TA, Strober W (1969) Metabolism of immunoglobulins. Progr Allergy 13: 1–110

    CAS  Google Scholar 

  • Walker GL (1979) Progressive polyradiculoneuropathy: treatment with azathioprine. Aust NZ J Med 9: 184–187

    Article  CAS  Google Scholar 

  • Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S (1980) Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244: 2423–2426

    Article  PubMed  CAS  Google Scholar 

  • Wood GJ, Hall GM (1978) Plasmapheresis and plasma cholesterase. Brit J Anaesth 50: 945–949

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinisch-wissenschaftliche Abteilung, Troponwerke GmbH & Co. KG, Berliner Straße 156, W-5000, Köln 80, Bundesrepublik Deutschland

    Priv.-Doz. Dr. med. Kurt Heininger

Authors
  1. Priv.-Doz. Dr. med. Kurt Heininger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heininger, K. (1993). Literatur. In: In-vitro- und in-vivo-Untersuchungen zur selektiven Immunadsorptionsbehandlung neurologischer Erkrankungen. Schriftenreihe Neurologie, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77092-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77092-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77093-7

  • Online ISBN: 978-3-642-77092-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation